中文
Products

Circulating tumor DNA (ctDNA) detection

The circulating tumor gene (circulating tumor DNA), ctDNA, is a characteristic tumor biomarker which enters into the circulatory system through shedding of tumor cell DNA or release after apoptosis Traces of tumor in the blood can be detected by detecting ctDNA

Intended Use

For early diagnosis of tumors, monitoring of tumor progression, prognosis evaluation non-invasively, and guidance for personalized medication.

Circulating tumor DNA (ctDNA) detection

Clinical Department

Clinical lab,ICU,oncology department, Surgical Ward and etc.

Product Parameters Clinical application

[Product name]Circulating tumor DNA (ctDNA) detection

[Intended Use]

For early diagnosis of tumors, monitoring of tumor progression, prognosis evaluation non-invasively, and guidance for personalized medication.

[Clinical Department]

Clinical lab,ICU,oncology department, Surgical Ward and etc.
(1)Non-invasive, non-destructive, real-time, repeatability;"Liquid biopsy" can be performed if tumor tissue cannot be obtained;

(2)Low false positive rate, high sensitivity, high accuracy and can be used for early diagnosis of tumor;

(3)It is able to monitor the progression and adaptive changes of tumor;

(4)It is able to monitor the treatment efficacy of patients with cancer in real time (especially in tracking the outcome, metastasis and recurrence of tumors, etc.), and guide personalized medication (such as personalized targeted drug use, personalized chemotherapy, etc.);

(5)More sensitive than other tumor markers;

(6)Low content (<  1% of total cfDNA);

(7)Short half-life (2 h)

(8)Short segment (180 - 200 bp).

微信公众平台

官网二维码